Source: Biomedical Reports. Unidade: IME
Subjects: POLIMORFISMO, ESTATÍSTICA APLICADA
ABNT
MELO, Mariella De Ameida et al. CYP2D6 gene polymorphisms in Brazilian patients with breast cancer treated with adjuvant tamoxifen and its association with disease recurrence. Biomedical Reports, v. 5, n. 5, p. 574-578, 2016Tradução . . Disponível em: https://doi.org/10.3892/br.2016.771. Acesso em: 09 out. 2024.APA
Melo, M. D. A., De Vasconcelos-Valença, R. J., Neto, F. M., Borges, R. S., Costa-Silva, D. R., Barros-Oliveira, M. da C., et al. (2016). CYP2D6 gene polymorphisms in Brazilian patients with breast cancer treated with adjuvant tamoxifen and its association with disease recurrence. Biomedical Reports, 5( 5), 574-578. doi:10.3892/br.2016.771NLM
Melo MDA, De Vasconcelos-Valença RJ, Neto FM, Borges RS, Costa-Silva DR, Barros-Oliveira M da C, Borges US, Alencar AP, Silva VC, da Silva BB. CYP2D6 gene polymorphisms in Brazilian patients with breast cancer treated with adjuvant tamoxifen and its association with disease recurrence [Internet]. Biomedical Reports. 2016 ; 5( 5): 574-578.[citado 2024 out. 09 ] Available from: https://doi.org/10.3892/br.2016.771Vancouver
Melo MDA, De Vasconcelos-Valença RJ, Neto FM, Borges RS, Costa-Silva DR, Barros-Oliveira M da C, Borges US, Alencar AP, Silva VC, da Silva BB. CYP2D6 gene polymorphisms in Brazilian patients with breast cancer treated with adjuvant tamoxifen and its association with disease recurrence [Internet]. Biomedical Reports. 2016 ; 5( 5): 574-578.[citado 2024 out. 09 ] Available from: https://doi.org/10.3892/br.2016.771